Higher plasma aldosterone concentrations in patients with aortic diseases and hypertension: a retrospective observational study
- PMID: 38008731
- PMCID: PMC10676595
- DOI: 10.1186/s40001-023-01528-2
Higher plasma aldosterone concentrations in patients with aortic diseases and hypertension: a retrospective observational study
Abstract
Background: Aortic diseases remain a highly perilous macrovascular condition. The relationship between circulating aldosterone and aortic diseases is rarely explored, thus we investigated the difference in plasma aldosterone concentration (PAC) between patients with and without aortic disease in hypertensive people.
Methods: We analyzed 926 patients with hypertension, ranging in age from 18 to 89 years, who had their PAC measured from the hospital's electronic database. The case group and control group were defined based on inclusion and exclusion criteria. The analysis included general information, clinical data, biochemical data, and medical imaging examination results as covariates. To further evaluate the difference in PAC between primary hypertension patients with aortic disease and those without, we used multivariate logistic regression analysis and also employed propensity score matching to minimize the influence of confounding factors.
Results: In total, 394 participants were included in the analysis, with 66 individuals diagnosed with aortic diseases and 328 in the control group. The participants were predominantly male (64.5%) and over the age of 50 (68.5%), with an average PAC of 19.95 ng/dL. After controlling for confounding factors, the results showed hypertension patients with aortic disease were more likely to have high PAC levels than those without aortic disease (OR = 1.138, 95% CI [1.062 to 1.238]). Subgroup analysis revealed consistent relationship between PAC and primary hypertensive patients with aortic disease across the different stratification variables. Additionally, hypertensive patients with aortic disease still have a risk of higher PAC levels than those without aortic disease, even after propensity score matching.
Conclusions: The results of this study suggest that primary hypertensive patients with aortic diseases have elevated levels of PAC, but the causal relationship between PAC and aortic disease requires further study.
Keywords: Aldosterone; Aortic diseases; Aortic dissection; Hypertension.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Higher Plasma Aldosterone Concentrations Are Associated With Elevated Risk of Aortic Dissection and Aneurysm: a Case-Control Study.Hypertension. 2022 Apr;79(4):736-746. doi: 10.1161/HYPERTENSIONAHA.121.18342. Epub 2022 Jan 12. Hypertension. 2022. PMID: 35016529
-
Positive Association Between Plasma Aldosterone Concentration and White Matter Lesions in Patients With Hypertension.Front Endocrinol (Lausanne). 2021 Nov 18;12:753074. doi: 10.3389/fendo.2021.753074. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34867798 Free PMC article.
-
Normokalemic hyperaldosteronism in patients with resistant hypertension.Isr Med Assoc J. 2002 Jan;4(1):17-20. Isr Med Assoc J. 2002. PMID: 11802302
-
Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism.Endocrine. 2022 Mar;75(3):889-898. doi: 10.1007/s12020-021-02920-w. Epub 2021 Nov 15. Endocrine. 2022. PMID: 34780033
-
Higher plasma aldosterone is associated with increased risk of cardiovascular events in hypertensive patients with suspected OSA: UROSAH data.Front Endocrinol (Lausanne). 2022 Oct 7;13:1017177. doi: 10.3389/fendo.2022.1017177. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36277704 Free PMC article.
References
-
- Erbel R, et al. Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC) Eur Heart J. 2014;35(41):2873–2926. doi: 10.1093/eurheartj/ehu281. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- kq2208330/Natural Science Foundation of Changsha
- 2023JJ40867/Natural Science Foundation of Hunan Province
- 2020SK1014-2/Key Project of Hunan Provincial Science and Technology Innovation
- 2019SK2022/Key Research and Development Program of Hunan Province
- 2022JGB008/Degree & Postgraduate Education Reform Project of Central South University
LinkOut - more resources
Full Text Sources
Medical